BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Alector

Alector logo

Founded
2013
Patents
20
Clinical Trials
8
Publications
11

Technologies

Pharmaceutical and Drug Discovery

Alector is a hypothesis-driven, neurology-focused startup that’s pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. We are combining state-of-the-art antibody technology and recent discoveries in neuro-immunology and human genetics to develop a broad platform of novel therapeutics that harness the immune system to fight dementia and neurodegeneration.


Posts Mentioning This Company

Companies Driving Innovation To Fight Alzheimer’s Disease

  
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even a century ago, led to a substantial growth of the population, and longer life expectancy for humans -- more and more people live up to their  60s, 70s, 80s and …